title: Post-market approval surveillance: a call for a more integrated and comprehensive approach.
authors.affiliation: Lenox Hill Heart and Vascular Institute, New York, NY, USA.
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: David A
authors.initials: DA
authors.lastname: Feigal
authors.forename: David
authors.initials: D
authors.lastname: Jefferys
authors.forename: Michael
authors.initials: M
authors.lastname: Simons
authors.forename: Nicholas
authors.initials: N
authors.lastname: Chronos
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Fogarty
authors.forename: Richard E
authors.initials: RE
authors.lastname: Kuntz
authors.forename: Donald S
authors.initials: DS
authors.lastname: Baim
authors.forename: Aaron V
authors.initials: AV
authors.lastname: Kaplan
mesh_terms: D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000628:therapy; D018795:Device Approval / Q000331:legislation & jurisprudence; D005062:European Union; D006801:Humans; D007391:International Cooperation; D015337:Multicenter Studies as Topic; D009204:Myocardial Revascularization; D011358:Product Surveillance, Postmarketing / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D015607:Stents; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration